Immunogenicity of combined anti-HIV and anti-suppressive vaccine preparations (original) (raw)

Key Issues for a Potential Human Immunodeficiency Virus Vaccine

Dale Hu

Clinical Infectious Diseases, 2003

View PDFchevron_right

Mucosal immunity and HIV/AIDS vaccines

Marc GIRARD

Vaccine, 2008

View PDFchevron_right

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

Susan Cu-uvin

Carolina Digital Repository (University of North Carolina at Chapel Hill), 2014

View PDFchevron_right

Immunopathology and Viral Reactivation

Bill Waltrip

The Journal of Nervous and Mental Disease, 1990

View PDFchevron_right

Malaria vaccines

Roberto Amador

Journal of Clinical Immunology, 1996

View PDFchevron_right

Therapeutic vaccines

James Gulley

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

Phillip Berman

New England Journal of Medicine, 2012

View PDFchevron_right

Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge

Nancy Haigwood

Proceedings of the National Academy of Sciences of the United States of America, 1992

View PDFchevron_right

Towards a genetic AIDS vaccine

Ben Berkhout

Retrovirology, 2009

View PDFchevron_right

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

Lorrin pang

Vaccine, 2005

View PDFchevron_right

Is there any room for therapeutic vaccination against the HIV-1/AIDS?

Shikhar Verma

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Antiretroviral Therapy in HIV Infection

Bruce j. Brew

Archives of Neurology, 2004

View PDFchevron_right

4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (Adjuvant 2008)

Oliver Perez

Expert Review of Vaccines, 2008

View PDFchevron_right

Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects

Naoki Yanagisawa

Vaccine, 2011

View PDFchevron_right

Simian Immunodeficiency Virus DNA Vaccine Trial in Macaques

Farah Mustafa

Annals of the New York Academy of Sciences, 1995

View PDFchevron_right

Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones

Nancy Haigwood

Cold Spring Harbor Perspectives in Medicine, 2012

View PDFchevron_right

The future of antiviral immunotoxins

Mette Rosenkilde

Journal of Leukocyte Biology, 2016

View PDFchevron_right

Mucosal Vaccination Strategies for Women

Susan Cu-uvin

The Journal of Infectious Diseases, 1999

View PDFchevron_right

Nucleic Acid Vaccines: Veterinary Applications

Lorne Babiuk

Current Topics in Microbiology and Immunology, 1998

View PDFchevron_right

Immune response induced by standard and fractional doses of 17DD yellow fever vaccine

Jandira Aparecida Campos Lemos

npj vaccines, 2024

View PDFchevron_right

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Phillip Berman

Journal of Infectious Diseases, 2012

View PDFchevron_right

HIV vaccine: it may take two to tango, but no party time yet

Ben Berkhout

Retrovirology, 2009

View PDFchevron_right

Immunisation registers – important for vaccinated individuals, vaccinators and public health

Pier Luigi Lopalco

Eurosurveillance, 2012

View PDFchevron_right

The race for a coronavirus vaccine

Nelson Santiago Vispo

Bionatura (Ibarra - Impresa), 2020

View PDFchevron_right

Herbal extracts as antiviral agents

Aini Ideris

Elsevier eBooks, 2020

View PDFchevron_right

Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients

Laurent Finkielsztejn

Journal of Immunological Methods, 1999

View PDFchevron_right

Lab-Immunology Research

Carlos Moreno

Neuro-Oncology, 2012

View PDFchevron_right

The Role of Antibody in Recovery from Infection with Vaccinia Virus

Robert Friedman

Journal of Immunology, 1961

View PDFchevron_right

Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals

Tandakha Dieye

Vaccine, 2001

View PDFchevron_right

Immunodeficiency and other clinical immunology

Domenico Lorello

Journal of Allergy and Clinical Immunology, 1998

View PDFchevron_right

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults

Jackton Indangasi

Molecular Therapy - Methods & Clinical Development, 2016

View PDFchevron_right

Hypothesis for COVID-19 Vaccine Detoxification

Yang I . Pachankis

Associative journal of health sciences, 2023

View PDFchevron_right

Immunogenicity and safety of an inactivated hepatitis a vaccine in anti-HIV positive and negative homosexual men

Fernando Guerra

Journal of Medical Virology, 1995

View PDFchevron_right

Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects

Tandakha Dieye

PLoS ONE, 2013

View PDFchevron_right

ERM immersion vaccination and adjuvants

Rzgar M Jaafar

2015

View PDFchevron_right